This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takano, A.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takano, A.
Right arrow Articles by Kobayashi, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2001, p. 5050-5062, Vol. 21, No. 15
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.15.5050-5062.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin

Atsuko Takano, Isao Usui, Tetsuro Haruta,* Junko Kawahara, Tatsuhito Uno, Minoru Iwata, and Masashi Kobayashi

First Department of Medicine, Toyama Medical and Pharmaceutical University, Toyama 930-0194, Japan

Received 21 November 2000/Returned for modification 16 January 2001/Accepted 9 May 2001

A pathway sensitive to rapamycin, a selective inhibitor of mammalian target of rapamycin (mTOR), down-regulates effects of insulin such as activation of Akt (protein kinase B) via proteasomal degradation of insulin receptor substrate 1 (IRS-1). We report here that the pathway also plays an important role in insulin-induced subcellular redistribution of IRS-1 from the low-density microsomes (LDM) to the cytosol. After prolonged insulin stimulation, inhibition of the redistribution of IRS-1 by rapamycin resulted in increased levels of IRS-1 and the associated phosphatidylinositol (PI) 3-kinase in both the LDM and cytosol, whereas the proteasome inhibitor lactacystin increased the levels only in the cytosol. Since rapamycin but not lactacystin enhances insulin-stimulated 2-deoxyglucose (2-DOG) uptake, IRS-1-associated PI 3-kinase localized at the LDM was suggested to be important in the regulation of glucose transport. The amino acid deprivation attenuated and the amino acid excess enhanced insulin-induced Ser/Thr phosphorylation and subcellular redistribution and degradation of IRS-1 in parallel with the effects on phosphorylation of p70 S6 kinase and 4E-BP1. Accordingly, the amino acid deprivation increased and the amino acid excess decreased insulin-stimulated activation of Akt and 2-DOG uptake. Furthermore, 2-DOG uptake was affected by amino acid availability even when the degradation of IRS-1 was inhibited by lactacystin. We propose that subcellular redistribution of IRS-1, regulated by the mTOR-dependent pathway, facilitates proteasomal degradation of IRS-1, thereby down-regulating Akt, and that the pathway also negatively regulates insulin-stimulated glucose transport, probably through the redistribution of IRS-1. This work identifies a novel function of mTOR that integrates nutritional signals and metabolic signals of insulin.


* Corresponding author. Mailing address: First Department of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. Phone: 81-764-34-2281. Fax: 81-764-34-5025. E-mail: tharuta-tym{at}umin.ac.jp.


Molecular and Cellular Biology, August 2001, p. 5050-5062, Vol. 21, No. 15
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.15.5050-5062.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dibble, C. C., Asara, J. M., Manning, B. D. (2009). Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1. Mol. Cell. Biol. 29: 5657-5670 [Abstract] [Full Text]  
  • Yuen, J. S.P., Akkaya, E., Wang, Y., Takiguchi, M., Peak, S., Sullivan, M., Protheroe, A. S., Macaulay, V. M. (2009). Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer. Molecular Cancer Therapeutics 8: 1448-1459 [Abstract] [Full Text]  
  • Scazzocchio, B., Vari, R., D'Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., Masella, R. (2009). Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. J. Lipid Res. 50: 832-845 [Abstract] [Full Text]  
  • Zhang, J., Gao, Z., Yin, J., Quon, M. J., Ye, J. (2008). S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-{alpha} Signaling through IKK2. J. Biol. Chem. 283: 35375-35382 [Abstract] [Full Text]  
  • Frangioudakis, G., Cooney, G. J (2008). Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling. J Endocrinol 197: 277-285 [Abstract] [Full Text]  
  • Marzec, M., Liu, X., Kasprzycka, M., Witkiewicz, A., Raghunath, P. N., El-Salem, M., Robertson, E., Odum, N., Wasik, M. A. (2008). IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. Blood 111: 2181-2189 [Abstract] [Full Text]  
  • Ravitz, M. J., Chen, L., Lynch, M., Schmidt, E. V. (2007). c-myc Repression of TSC2 Contributes to Control of Translation Initiation and Myc-Induced Transformation. Cancer Res. 67: 11209-11217 [Abstract] [Full Text]  
  • Tremblay, F., Brule, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., Marette, A. (2007). Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104: 14056-14061 [Abstract] [Full Text]  
  • Oshiro, N., Takahashi, R., Yoshino, K.-i., Tanimura, K., Nakashima, A., Eguchi, S., Miyamoto, T., Hara, K., Takehana, K., Avruch, J., Kikkawa, U., Yonezawa, K. (2007). The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1. J. Biol. Chem. 282: 20329-20339 [Abstract] [Full Text]  
  • Ishizuka, K., Usui, I., Kanatani, Y., Bukhari, A., He, J., Fujisaka, S., Yamazaki, Y., Suzuki, H., Hiratani, K., Ishiki, M., Iwata, M., Urakaze, M., Haruta, T., Kobayashi, M. (2007). Chronic Tumor Necrosis Factor-{alpha} Treatment Causes Insulin Resistance via Insulin Receptor Substrate-1 Serine Phosphorylation and Suppressor of Cytokine Signaling-3 Induction in 3T3-L1 Adipocytes. Endocrinology 148: 2994-3003 [Abstract] [Full Text]  
  • Doi, M., Yamaoka, I., Nakayama, M., Sugahara, K., Yoshizawa, F. (2007). Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 292: E1683-E1693 [Abstract] [Full Text]  
  • Jager, J., Gremeaux, T., Cormont, M., Le Marchand-Brustel, Y., Tanti, J.-F. (2007). Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression. Endocrinology 148: 241-251 [Abstract] [Full Text]  
  • Shah, O. J., Hunter, T. (2006). Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis.. Mol. Cell. Biol. 26: 6425-6434 [Abstract] [Full Text]  
  • Yan, H., Frost, P., Shi, Y., Hoang, B., Sharma, S., Fisher, M., Gera, J., Lichtenstein, A. (2006). Mechanism by Which Mammalian Target of Rapamycin Inhibitors Sensitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis. Cancer Res. 66: 2305-2313 [Abstract] [Full Text]  
  • Nagira, K., Sasaoka, T., Wada, T., Fukui, K., Ikubo, M., Hori, S., Tsuneki, H., Saito, S., Kobayashi, M. (2006). Altered Subcellular Distribution of Estrogen Receptor {alpha} Is Implicated in Estradiol-Induced Dual Regulation of Insulin Signaling in 3T3-L1 Adipocytes. Endocrinology 147: 1020-1028 [Abstract] [Full Text]  
  • He, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., Kobayashi, M. (2006). Interleukin-1{alpha} Inhibits Insulin Signaling with Phosphorylating Insulin Receptor Substrate-1 on Serine Residues in 3T3-L1 Adipocytes. Mol. Endocrinol. 20: 114-124 [Abstract] [Full Text]  
  • Usui, I., Imamura, T., Babendure, J. L., Satoh, H., Lu, J.-C., Hupfeld, C. J., Olefsky, J. M. (2005). G Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both G{alpha}q/11 and Insulin Receptor Substrate-1 Pathways in 3T3-L1 Adipocytes. Mol. Endocrinol. 19: 2760-2768 [Abstract] [Full Text]  
  • Danielsson, A., Ost, A., Nystrom, F. H., Stralfors, P. (2005). Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes. J. Biol. Chem. 280: 34389-34392 [Abstract] [Full Text]  
  • Shi, Y., Yan, H., Frost, P., Gera, J., Lichtenstein, A. (2005). Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Molecular Cancer Therapeutics 4: 1533-1540 [Abstract] [Full Text]  
  • Wlodarski, P., Kasprzycka, M., Liu, X., Marzec, M., Robertson, E. S., Slupianek, A., Wasik, M. A. (2005). Activation of Mammalian Target of Rapamycin in Transformed B Lymphocytes Is Nutrient Dependent but Independent of Akt, Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase, Insulin Growth Factor-I, and Serum. Cancer Res. 65: 7800-7808 [Abstract] [Full Text]  
  • Nair, K. S., Short, K. R. (2005). Hormonal and Signaling Role of Branched-Chain Amino Acids. J. Nutr. 135: 1547S-1552S [Abstract] [Full Text]  
  • Inoki, K., Ouyang, H., Li, Y., Guan, K.-L. (2005). Signaling by Target of Rapamycin Proteins in Cell Growth Control. Microbiol. Mol. Biol. Rev. 69: 79-100 [Abstract] [Full Text]  
  • Tremblay, F., Gagnon, A., Veilleux, A., Sorisky, A., Marette, A. (2005). Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes. Endocrinology 146: 1328-1337 [Abstract] [Full Text]  
  • Khamzina, L., Veilleux, A., Bergeron, S., Marette, A. (2005). Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance. Endocrinology 146: 1473-1481 [Abstract] [Full Text]  
  • Rhodes, C. J. (2005). Type 2 Diabetes-a Matter of {beta}-Cell Life and Death?. Science 307: 380-384 [Abstract] [Full Text]  
  • Briaud, I., Dickson, L. M., Lingohr, M. K., McCuaig, J. F., Lawrence, J. C., Rhodes, C. J. (2005). Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells. J. Biol. Chem. 280: 2282-2293 [Abstract] [Full Text]  
  • Baum, J. I., O'Connor, J. C., Seyler, J. E., Anthony, T. G., Freund, G. G., Layman, D. K. (2005). Leucine reduces the duration of insulin-induced PI 3-kinase activity in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288: E86-E91 [Abstract] [Full Text]  
  • Manning, B. D. (2004). Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. JCB 167: 399-403 [Abstract] [Full Text]  
  • Usui, I., Imamura, T., Huang, J., Satoh, H., Shenoy, S. K., Lefkowitz, R. J., Hupfeld, C. J., Olefsky, J. M. (2004). {beta}-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1. Mol. Cell. Biol. 24: 8929-8937 [Abstract] [Full Text]  
  • Murakami, S., Sasaoka, T., Wada, T., Fukui, K., Nagira, K., Ishihara, H., Usui, I., Kobayashi, M. (2004). Impact of Src Homology 2-Containing Inositol 5'-Phosphatase 2 on the Regulation of Insulin Signaling Leading to Protein Synthesis in 3T3-L1 Adipocytes Cultured with Excess Amino Acids. Endocrinology 145: 3215-3223 [Abstract] [Full Text]  
  • Cheng, S. W. Y., Fryer, L. G. D., Carling, D., Shepherd, P. R. (2004). Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status. J. Biol. Chem. 279: 15719-15722 [Abstract] [Full Text]  
  • Browne, G. J., Proud, C. G. (2004). A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin. Mol. Cell. Biol. 24: 2986-2997 [Abstract] [Full Text]  
  • Gual, P., Gonzalez, T., Gremeaux, T., Barres, R., Le Marchand-Brustel, Y., Tanti, J.-F. (2003). Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes. J. Biol. Chem. 278: 26550-26557 [Abstract] [Full Text]  
  • Meijer, A. J. (2003). Amino Acids as Regulators and Components of Nonproteinogenic Pathways. J. Nutr. 133: 2057S-2062 [Abstract] [Full Text]  
  • Usui, I., Imamura, T., Huang, J., Satoh, H., Olefsky, J. M. (2003). Cdc42 Is a Rho GTPase Family Member That Can Mediate Insulin Signaling to Glucose Transport in 3T3-L1 Adipocytes. J. Biol. Chem. 278: 13765-13774 [Abstract] [Full Text]  
  • Greene, M. W., Sakaue, H., Wang, L., Alessi, D. R., Roth, R. A. (2003). Modulation of Insulin-stimulated Degradation of Human Insulin Receptor Substrate-1 by Serine 312 Phosphorylation. J. Biol. Chem. 278: 8199-8211 [Abstract] [Full Text]  
  • HUMAR, R., KIEFER, F. N., BERNS, H., RESINK, T. J., BATTEGAY, E. J. (2002). Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling. FASEB J. 16: 771-780 [Abstract] [Full Text]  
  • Zhande, R., Mitchell, J. J., Wu, J., Sun, X. J. (2002). Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1. Mol. Cell. Biol. 22: 1016-1026 [Abstract] [Full Text]